Headquartered in New York City, Aetion is a leading real-world evidence and healthcare data science platform company with 300+ employees serving pharmaceutical, biotech, and payer organizations. Aetion’s Evidence Platform enables rapid generation of regulatory-grade real-world evidence using claims, EHR, and registry data through automated statistical analysis, machine learning, and causal inference methodologies. Clients include 19 of the top 20 pharmaceutical companies, the FDA, and major health plans. Aetion has published 200+ peer-reviewed studies demonstrating the validity of their data science approach. Raised $150 million in funding, Aetion is transforming how the life sciences industry uses real-world data for drug development and regulatory submissions.